Yang Y, Sun J, Wang Z, Fang J, et al. Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus
Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or
Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study. J Thorac Oncol 2021;16:2109-2120.
PMID: 34358724